COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, INC.Common Stock Purchase Warrant • June 28th, 2010 • Palatin Technologies Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times on or after the date hereof (the “Exercisability Date”), but not after 11:59 p.m., New York City time, on June ___, 2011 (the “Termination Date”), to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock.
COMMON STOCK PURCHASE WARRANT PALATIN TECHNOLOGIES, INC.Palatin Technologies Inc • June 28th, 2010 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times on or after the date hereof (the “Exercisability Date”), but not after 11:59 p.m., New York City time, on November 26, 2012 (the “Termination Date”), to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. This Warrant is issued by the Company as of the date hereof pursuant to (i) Section 1 of the Engagement Agreement, dated June 25, 2010, by and between the Company and Rodman & Renshaw, LLC and (ii) Section 4(2) of the Securities Act and Rule 506 promulgated thereunder.
CONFIDENTIALPalatin Technologies Inc • June 28th, 2010 • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 28th, 2010 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 25, 2010, between Palatin Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PALATIN TECHNOLOGIES, INC. Waiver of Right of Participation and Amendment to the Series B Common Stock Purchase WarrantsSecurities Purchase Agreement • June 28th, 2010 • Palatin Technologies Inc • Pharmaceutical preparations
Reference is made to that certain Securities Purchase Agreement (the “SPA”), dated as of February 24, 2010, by and between Palatin Technologies, Inc. (the “Company”) and the undersigned purchaser of the Company’s common stock, par value per share $0.01 (“Common Stock”), Series A Common Stock Purchase Warrant and Series B Common Stock Purchase Warrant (“Series B Warrant”). The Company is currently in discussions with certain institutional investors for the sale of Common Stock and warrants to purchase Common Stock on terms that have been disclosed to you by our placement agent, Rodman & Renshaw, LLC (the “Proposed Financing”).
